Apollomics Announces Presentations of Vebreltinib Data at ESMO 2023

17.10.2023 - FOSTER CITY, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) - Apollomics Inc. (Nasdaq: APLM) (the “Company”), a late-stage clinical biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and ... Seite 1

Related Keywords

Guangdong ,Jilin ,China ,Italy ,Veneto ,Kunpeng ,Guangzhou ,Jin Ji Yang ,Guo Liang Yu ,Giulia Cerretti Veneto Institute Of Oncology ,Southern Medical University ,Veneto Institute Of Oncology ,Guangdong Academy Of Medical Sciences ,Guangdong Lung Cancer Institute ,Chief Executive Officer ,Preliminary Results ,Guangdong Provincial People ,Guangdong Academy ,Medical Sciences ,Veneto Institute ,Giulia Cerretti ,Mini Oral ,Apollomics Chart ,Pollomics Kurs ,Pollomics Aktie ,